Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07850401

STRATA: Surgical Treatment Using Robotic Approach in The Acute Abdomen

STRATA: Surgical Treatment Using Robotic Approach in The Acute Abdomen — Recruiting • NCT07850401.

📅 30 Sep 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07850401
Start
2026-07-24
Completion
2028-07-20
ClinicaliQ Trial Snapshot
  • STRATA: Surgical Treatment Using Robotic Approach in The Acute Abdomen — Recruiting • NCT07850401.
  • STRATA Trial Summary.
  • Robotic surgery in emergency abdominal surgery improves outcomes and patient satisfaction compared to open or laparoscopic approaches.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Robotic surgery in the UK is now widely used in elective procedures based on evidence that it can improve outcomes, with improved vision and precision for the surgeon resulting in better results and greater rates of minimally invasive surgery. Despite this, there remain some concerns about its use with some saying it adds cost with limited or no benefit to patients. Its application in the emergency setting has not been well studied. However, emergency patients are the sickest patients, and so stand to potentially gain the most from robotic surgery,…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn